H.R. 2589 (119th)Bill Overview

Consensual Donation and Research Integrity Act of 2025

Health|Health
Cosponsors
Support
Bipartisan
Introduced
Apr 2, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill amends the Public Health Service Act to require entities that acquire and sell for profit whole human bodies or body parts (for non-transplant purposes) to register with the HHS Secretary. It mandates inspections, recordkeeping, chain-of-custody labeling and packaging, limits on use and disclosure of donor-identifiable information, and requirements for disposition.

Why people may split

Progressives emphasize donor protections and privacy benefits

Watch point

Relative to its intended legislative type, this bill is a substantive statutory enactment that establishes a federal regulatory framework for commercial acquisition and sale of human bodies and body parts for non-transplant educational and research uses.

The bill amends the Public Health Service Act to require entities that acquire and sell for profit whole human bodies or body parts (for non-transplant purposes) to register with the HHS Secretary.

It mandates inspections, recordkeeping, chain-of-custody labeling and packaging, limits on use and disclosure of donor-identifiable information, and requirements for disposition.

The Secretary may assess fees, suspend or revoke registrations, and violations carry fines under Title 18 and a prohibition on label falsification.

Passage40/100

Technocratic, limited‑cost bill with consumer‑protection framing improves prospects, but industry resistance, federalism questions, and procedural hurdles reduce odds.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a substantive statutory enactment that establishes a federal regulatory framework for commercial acquisition and sale of human bodies and body parts for non-transplant educational and research uses. It defines key obligations, definitions, and sanctions while delegating implementation specifics to the Secretary.

Contention55/100

Progressives emphasize donor protections and privacy benefits

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Federal agenciesLikely burdened

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Federal agenciesCreates federal standards protecting donor consent and disposition across state lines.
  • Potential benefitImproves traceability and chain-of-custody, potentially reducing illicit sales and misuses.
  • Potential benefitLikely increases public trust in donations to education and research institutions.
Likely burdened
  • Potential burdenImposes new compliance costs and administrative burdens on for‑profit body and tissue brokers.
  • Potential burdenCould reduce available specimen supply if sellers exit due to regulatory costs or uncertainty.
  • Potential burdenLabeling requirements including donor identifiers raise potential privacy and confidentiality concerns.
03 · Why people split

Why the argument around this bill splits.

Progressives emphasize donor protections and privacy benefits
Progressive85%

Likely supportive because the bill strengthens consent, privacy, and respectful treatment of donated remains used in research and education.

It addresses documented abuses by commercial body brokers by requiring transparency, records, and disposal obligations.

Supporters may nonetheless seek stronger enforcement funding and civil remedies for harmed families.

Leans supportive
Centrist70%

Generally favorable as a targeted consumer-protection and transparency measure balancing research needs.

The bill appears administrable but raises pragmatic questions about fee levels, regulatory overlap with states, and enforcement capacity.

Centrists will weigh benefits against administrative cost and clarity about interactions with existing laws.

Leans supportive
Conservative35%

Mixed to skeptical: supports protecting donors from abuse but worries the bill expands federal regulation into areas traditionally governed by states and funeral professionals.

Concerns include regulatory burden, fees, inspections, and potential interference with medical research supply chains.

Conservatives may push for narrower federal scope or stronger state primacy.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood40/100

Technocratic, limited‑cost bill with consumer‑protection framing improves prospects, but industry resistance, federalism questions, and procedural hurdles reduce odds.

Scope and complexity
52%
Scopemoderate
52%
Complexitymedium
Why this could stall
  • Cost and adequacy of fee revenue and appropriations
  • How "sell for profit" will be interpreted and litigated
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Progressives emphasize donor protections and privacy benefits

Technocratic, limited‑cost bill with consumer‑protection framing improves prospects, but industry resistance, federalism questions, and pro…

Unlocked analysis

Relative to its intended legislative type, this bill is a substantive statutory enactment that establishes a federal regulatory framework for commercial acquisition and sale of human bodies and body parts for non-transp…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis